Nous utilisons des cookies pour nous assurer que nous vous offrons la meilleure expérience possible sur notre site web.
The startup quickly becomes a success, but is also confronted with more restrictive regulations and lower prices for prostheses in Europe. Jacques Essinger leaves the company and Jean Plé takes over the management and control of Symbios. He adapts the strategy to extend the product portfolio to standard prostheses in order to appeal to a larger market than that of custom-made prostheses.